
Hear Dr. Ryan Dorfman, Prolytix, discuss moving from one-time validation to lifecycle bioassay management, with Q&A from Matthew Whelihan, Vera Bretton and Richard Pouliot on stronger assays, reg readiness and biologics decision-making.
Register here: eu1.hubs.ly/H0x7Rdh0

English

















